Bristol-Myers Squibb (BMY) News Today → Don’t buy a single NVIDIA share before you see this... (From Behind the Markets) (Ad) Free BMY Stock Alerts $41.09 +0.84 (+2.09%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 12:35 PM | marketbeat.comChiron Capital Management LLC Sells 25,095 Shares of Bristol-Myers Squibb (NYSE:BMY)Chiron Capital Management LLC lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 5.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 444,615 shares of the biopharmaceutical company's stock after selling 25,095 shares during the quaJune 1 at 8:00 AM | businesswire.comKRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung CancerMay 31 at 9:32 PM | marketbeat.comPingora Partners LLC Makes New $1.06 Million Investment in Bristol-Myers Squibb (NYSE:BMY)Pingora Partners LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,684 shares of the biopharmaceutical compMay 31 at 2:42 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Up 1.1%Bristol-Myers Squibb (NYSE:BMY) Shares Up 1.1%May 31 at 2:18 AM | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Receives $60.00 Consensus PT from BrokeragesMay 30 at 3:57 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Position Increased by Fiduciary Trust CoFiduciary Trust Co lifted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 222,208 shares of the biopharmaceutical company's stock after buying an additional 30,257 shareMay 30 at 1:45 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Up 0.4%Bristol-Myers Squibb (NYSE:BMY) Shares Up 0.4%May 30 at 11:59 AM | reuters.comUS FDA allows use of Bristol's cell therapy for rare blood cancerMay 30 at 11:51 AM | businesswire.comU.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell LymphomaMay 30 at 6:20 AM | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Reaches New 12-Month Low at $41.04May 29 at 6:45 PM | marketbeat.comTFO Wealth Partners LLC Has $1.05 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)TFO Wealth Partners LLC grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 48,673.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,485 shares of the biopharmaceutical company'sMay 29 at 2:30 PM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.9%Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.9%May 29 at 2:02 PM | msn.comBristol-Myers gets EU approval for Opdivo for bladder cancerMay 29 at 7:14 AM | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.7%May 29 at 6:59 AM | businesswire.comBristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial CarcinomaMay 28, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Journey Advisory Group LLCJourney Advisory Group LLC decreased its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 50.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,040 shares of the biopharmaceutical compMay 28, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.8%Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.8%May 28, 2024 | finance.yahoo.comASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income CountriesMay 28, 2024 | stocknews.comDividend Stability and Growth in Pharma: Pfizer (PFE) vs. Bristol-Myers Squibb (BMY)May 28, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Hits New 1-Year Low at $41.04Bristol-Myers Squibb (NYSE:BMY) Sets New 1-Year Low at $41.04May 28, 2024 | businesswire.comMenten AI Announces Completion of Research Collaboration with Bristol Myers SquibbMay 28, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Receives Average Recommendation of "Hold" from BrokeragesBristol-Myers Squibb (NYSE:BMY - Get Free Report) has been assigned an average rating of "Hold" from the nineteen ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation aMay 27, 2024 | marketbeat.comUnited Services Automobile Association Acquires 542,253 Shares of Bristol-Myers Squibb (NYSE:BMY)United Services Automobile Association increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 965.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 598,432 shares of theMay 27, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Down 0.7%Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.7%May 27, 2024 | investorplace.com3 Blue-Chip Stocks to Buy at 52-Week Lows in MayMay 27, 2024 | americanbankingnews.comQ2 2025 Earnings Estimate for Bristol-Myers Squibb (NYSE:BMY) Issued By Zacks ResearchMay 26, 2024 | marketbeat.com234,174 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Cantor Fitzgerald Investment Advisors L.P.Cantor Fitzgerald Investment Advisors L.P. purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 234,174 shares of the biopharmaceMay 26, 2024 | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Shares Down 0.7% May 25, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Nomura Asset Management Co. Ltd.Nomura Asset Management Co. Ltd. lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 971,591 shares of the biopharmaceuticaMay 25, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Stake Raised by Primecap Management Co. CAPrimecap Management Co. CA grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,534,378 shares of the biopharmaceMay 24, 2024 | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Upgraded to "Strong-Buy" by StockNews.comMay 24, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Upgraded to "Strong-Buy" at StockNews.comStockNews.com upgraded shares of Bristol-Myers Squibb from a "buy" rating to a "strong-buy" rating in a report on Thursday.May 23, 2024 | marketbeat.comOxford Asset Management LLP Buys New Position in Bristol-Myers Squibb (NYSE:BMY)Oxford Asset Management LLP acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 20,713 shares of the biopharmaceutical company's stock, vaMay 23, 2024 | businesswire.comBristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research PlatformsMay 23, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Down 1.1% Bristol-Myers Squibb (NYSE:BMY) Trading Down 1.1%May 23, 2024 | seekingalpha.comBristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying OpportunityMay 23, 2024 | finance.yahoo.comDoes Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?May 23, 2024 | cnbc.comThis up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&AMay 23, 2024 | fool.comThis Unpopular Dividend Stock Is a BuyMay 23, 2024 | fool.comThis Unpopular Dividend Stock Is a BuyMay 23, 2024 | businesswire.comBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual MeetingMay 22, 2024 | msn.comBristol-Myers Squibb snaps six days of losses, trades in the greenMay 22, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Holdings Decreased by Oxler Private Wealth LLCOxler Private Wealth LLC reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 72.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,925 shares of the biopharmaceutical company's stock afterMay 22, 2024 | finance.yahoo.comPfizer to Cut Costs in Multi-Year EffortMay 22, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading 1.2% Higher Bristol-Myers Squibb (NYSE:BMY) Trading 1.2% HigherMay 22, 2024 | reuters.comBristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 millionMay 22, 2024 | finance.yahoo.comBristol-Myers Squibb Announces Strategies to Improve Access to MedicinesMay 22, 2024 | businesswire.comBristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income CountriesMay 22, 2024 | prnewswire.comNeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers SquibbMay 21, 2024 | marketbeat.comOxler Private Wealth LLC Has $1.66 Million Position in Bristol-Myers Squibb (NYSE:BMY)Oxler Private Wealth LLC lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 285.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,552 shares of the biopharmaceutical company's stock afte Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address [Urgent!] Generational Wealth Gameplan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide BMY Media Mentions By Week BMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼0.780.78▲Average Medical News Sentiment BMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼3123▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Corcept Therapeutics News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
